YARW
Yarrow Bioscience Inc
22.30$
-5.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4,519.3% | -6,759.2% | -8,143.9% | -4,283.8% | -7,033.1% | -10,713.1% | -5,673.8% | -15,656.5% | -4,198.8% | -2,895.4% | -4,745.3% | -2,053.6% | -3,513.1% | |
| – | – | – | – | – | 4.8% | 3.0% | 8.7% | 3.6% | 3.8% | -14.0% | 6.2% | 1.0% | |
| 757.0% | 934.2% | 1,005.1% | 447.0% | 606.6% | 832.1% | 377.7% | 766.7% | 288.2% | 406.9% | 551.2% | 449.5% | 399.6% | |
| 499.1% | 782.9% | -1,978.6% | 330.8% | 2,824.8% | 3,410.7% | -1,631.2% | -7,781.2% | -94.1% | 483.8% | -1,114.0% | 987.6% | 97.5% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 139.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | -82,044.7% | -3,641.8% | 9,606.1% | -3,986.8% | 15,164.3% | 9,817.3% | 6,775.4% | 2,604.7% | 6,507.7% | 5,465.1% | 309.3% | 3,705.8% | |
| – | – | – | – | – | – | – | -49.3% | -4.1% | -11.5% | – | – | – | |
| -41.2% | 108,767.1% | -5.1% | -1.0% | -1.7% | -157.1% | -43.1% | -49.3% | -4.1% | -11.5% | -17.4% | -14.4% | -10.6% | |
| -4,560.5% | 19,963.2% | -11,790.8% | 5,321.2% | -11,021.5% | 4,294.0% | 4,100.5% | -8,930.4% | -1,598.2% | 3,600.8% | 702.3% | -1,758.8% | 182.2% | |
| -4,519.3% | -6,759.2% | -8,143.9% | -4,283.8% | -7,033.1% | -10,852.4% | -5,673.8% | -15,656.5% | -4,198.8% | -2,895.4% | -4,745.3% | -2,053.6% | -3,513.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.